GLP-1-based diabetes therapies; trial by media.
Diabetic Medicine.
G A
GA
Hitman
R D
RD
Leslie
R I G
RI
Holt
D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D000067757:Glucagon-Like Peptide-1 Receptor; D006801:Humans; D054795:Incretins / Q000009:adverse effects*; D033181:Information Dissemination; D008297:Male; D008402:Mass Media; D010182:Pancreatic Diseases / Q000139:chemically induced*; D018027:Receptors, Glucagon / Q000187:drug effects*; D018570:Risk Assessment; D013690:Television
C000593833:GLP1R protein, human; D000067757:Glucagon-Like Peptide-1 Receptor; D054795:Incretins; D018027:Receptors, Glucagon